In vitro activity of selected antimicrobials against methicillin-resistant Staphylococcus pseudintermedius of canine

Magdalena Kizerwetter-Świda1, Dorota Chrobak-Chmiel1, Ilona Stefańska1

  • 1Department of Preclinical Sciences, Institute of Veterinary Medicine, Warsaw University of Life Sciences, Warsaw, Poland.

PubMed
Abstract

Insights

Methicillin-resistant Staphylococcus pseudintermedius (MRSP) in dogs shows high resistance to common antibiotics. Amikacin and vancomycin remain effective, offering potential treatment options for MRSP infections.

Area of Science:

  • Veterinary Microbiology
  • Antimicrobial Resistance
  • Companion Animal Health

Background:

  • Methicillin-resistant Staphylococcus pseudintermedius (MRSP) is a significant veterinary pathogen.
  • Limited antimicrobial options are typically effective against MRSP isolates.
  • Canine MRSP infections pose a growing clinical challenge.

Purpose of the Study:

  • To evaluate the in vitro activity of selected antimicrobials against clinical MRSP isolates from dogs.
  • To assess the efficacy of last-choice drugs against canine MRSP.
  • To identify potential therapeutic agents for MRSP infections in companion animals.

Main Methods:

  • Antimicrobial susceptibility testing (AST) was performed on 41 clinical MRSP isolates.
  • Disk diffusion and minimal inhibitory concentration (MIC) methods were utilized.
  • Guidelines for staphylococci of canine or human origin were applied for interpretation.

Main Results:

  • High prevalence of resistance was observed for enrofloxacin (97.6%) and clindamycin (97.6%).
  • Resistance to doxycycline (83.0%) and gentamicin (68.3%) was also common.
  • All isolates remained susceptible to amikacin, vancomycin, mupirocin, and linezolid.

Conclusions:

  • Amikacin and vancomycin are potential treatment options for MRSP infections in dogs.
  • Extended susceptibility testing for agents like amikacin and chloramphenicol is recommended.
  • Establishing clinical breakpoints for veterinary-specific antimicrobials is crucial for diagnostics.

Related Concept Videos

Antibiotic Selection00:57

Antibiotic Selection

Overview
Antimicrobial Effectiveness01:28

Antimicrobial Effectiveness

The effectiveness of antimicrobial agents depends on various factors influencing their ability to eliminate microbial populations. Larger microbial populations require more time for complete eradication, emphasizing the importance of population size analysis when evaluating antimicrobial efficacy.Microbial resistance to antimicrobial agents varies significantly. Highly resilient microorganisms include endospores, gram-negative bacteria, and non-enveloped viruses, while prions are exceptionally...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...